Warfarin therapy initiated before is more beneficial than after transesophageal echocardiography detected left atrial thrombus

Echocardiography

Volumn 24, Issue 1, 2007, Pages 14-19

  Shen, Xuedong ^a   Li, Huagui ^a   Nair, Chandra K ^a   Holmberg, Mark J ^a   Lakkireddy, Dhanunjay ^a   Cloutier, David ^a   Rovang, Karen ^a   Hee, Tom ^a   Mooss, Aryan N ^a   Mohiuddin, Syed M ^a  

^a CREIGHTON UNIVERSITY CARDIAC CENTER   (United States)

Author keywords

Atrial fibrillation; Cardioversion; Thromboembolism; Transesophageal echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK; THROMBOEMBOLISM; THROMBOSIS; TIME FACTORS; WARFARIN;

EID: 33845981047     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2007.00344.x     Document Type: Article

References (34)

1. Petersen P, Boysen G, Godtfredsen J, et al: Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhahen AFASAK study. Lancet 1989;1:175-178.
2. Schlicht JR, Davis RC, Naqi K, et al: Physician practices regarding anticoagulation and cardioversion of atrial fibrillation. Arch Intern Med 1996;156:290-294.
3. Carlsson J, Tebbe U, Rox J, et al: Cardioversion of atrial fibrillation in the elderly. Am J Cardiol 1996;78:1380-1384.
4. Xuedong S, Huagui L, Karen R, et al: Prevalence of intraatrial thrombi in atrial fibrillation patients with sub-therapeutic INRs while on conventional anticoagulation. Am J Cardiol 2002;90(15):660-662.
5. Tsai LM, Chen JH, Lin LJ, et al: Role of transesophageal echocardiography in detecting left atrial thrombus and spontaneous echo contrast in patients with mitral valve disease or non-rheumatic atrial fibrillation. J Formos Med Assoc 1990;89(4):270-274.
6. Corrado G, Santarone M, Beretta S, et al: Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8.5-year experience. Europace 2000;2(2):119-126.
7. Corrado G, Tadeo G, Beretta S, et al: Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest 1999;115(1):140-143.
8. Chan M, Marcus R, Bednarz J, et al: Contribution of transesophageal echocardiography to exclude the presence of atrial thrombi [abstract]. J Am Soc Echocardiogr 1992;5:308.
9. Stoddard MF, Longaker RA: Role of transesophageal echo prior to cardioversion in patients with atrial fibrillation [abstract]. J Am Coll Cardiol 1993;21(Suppl. A):28A.
10. Fuster V, Ryden LE, Asinger RW, et al: ACC/AHA/ESC guideline for the management of patients with atrial fibrillation: Executive summary. Circulation 2001;104:2118-2150.
11. Montgomery DH, Ververis JJ, McGorisk G, et al: Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic study. J Am Coll Cardiol 1996;27:95-101.
12. The Boston Area Anticoagulation Trial For Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
13. Ezekowitz MD, Bridgers SL, James KE, et al: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992;327:1406-1412.
14. Connolly SJ, Laupacis A, Gent M, et al: Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 1991;18:349-355.
15. The EAFT Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993;342:1255-1262.
16. The Stroke Prevention in Atrial Fibrillation Investigators. The Stroke Prevention in Atrial Fibrillation study: Final results. Circulation 1991;84:527-539.
17. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet 1994;343:687-691.
18. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-638.
19. Li-Saw-Hee FL, Blann AD, Lip GY: Effect of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thromogenesis in chronic atrial fibrillation. Stroke 2000;31(4):828-833.
20. Samsa GP, Matchar DB, Goldstein LB, et al: Quality of anticoagulation management among patients with atrial fibrillation: Results of a review of medical records from 2 communities. Arch Intern Med 2000;160(7):967-973.
21. Klein AL, Grimm RA, Murray RD, et al: Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344(19):1411-1420.
22. Mayet J, More RS, Sutton GC: Anticoagulation for cardioversion of atrial arrhythmias. Eur Heart J 1998;19(4):548-552.
23. Jung F, DiMarco JP: Treatment strategies for atrial fibrillation. Am J Med 1998;104(3):272-286.
24. Mendelson G, Aronow WS: Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc 1998;46:1423-1424.
25. Nademanee K, Kosar EM: Long-term antithrombotic treatment for atrial fibrillation. Am J Cardiol 1998;82:37N-42N.
26. Charles C, Gornick MD: Anticoagulant use in nonvalvular atrial fibrillation: Determining risk and choosing the safest course. Postgrad Med 2000;108(2):113-126.
27. Jaber WA, Prior DL, Thamilarasan M, et al: Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. Am Heart J 2000;140(1):150-156.
28. Collins LJ, Silverman DI, Douglas PS, et al: Cardioversion of nonrheumatic atrial fibrillation: Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are elated to atrial thrombus resolution. Circulation 1995;92:160-163.
29. Grimm RA, Stewart WJ, Maloney JD, et al: Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993;22:1359-1366.
30. Fatkin D, Kuchar DL, Thorburn CW, et al: Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307-316.
31. Black IW, Hopkins AP, Lee LC, et al: Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993;126(2):375-381.
32. Physician's Desk Reference. Medical Economics 1997, Edition 51, pp 941.
33. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: Echocardiographic features of patients at risk. Ann Intern Med. 1992;116:6-12.
34. Blackshear JL, Pearce LA, Asinger RW, et al: Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation: Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol 1993;72:840-843.